Databricks Leads AI Startup Funding with $500M Round, Nvidia Backs Multiple Companies

Databricks raises $500M Series I at $43B valuation, including investment from Nvidia
Generate Biomedicines raises $273M Series C for AI drug discovery platform
Lyten raises $200M Series B for advanced materials and lithium-sulfur batteries
EquipmentShare raises $150M extension to April round, now totaling $440M
Enfabrica raises $125M Series B led by Atreides for AI networking chips, with investment from Nvidia

crunchbase.com

Relevant topic timeline:

8/18/2023

The Week’s 10 Biggest Funding Rounds: Biotech Startup Abcuro Takes Top Spot

Main Topic: Largest startup funding deals in the US in 2023 Key Points: 1. Abcuro raises $155 million in a Series B financing round for biotech. 2. Teamshares secures $124 million in a Series D round for fintech. 3. Pivotal Commware receives $102 million in a Series D round for telecommunications.

8/21/2023

Berlin-based Lykon raises further €2.5 million to help 1 million people lose weight sustainably

Main topic: Food & healthtech company Lykon raises €2.5 million in funding round. Key points: 1. Lykon aims to be a market leader for personalised nutrition programmes and products based on certified blood and DNA tests. 2. Lykon's goal is to help 1 million people achieve a healthy weight goal and avoid health issues such as diabetes and depression. 3. The funding will be used to develop new products and services to fight the obesity epidemic in Europe.

8/21/2023

A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $200M

California-based startup Genesis Therapeutics has raised $200 million in Series B funding, led by Andreessen Horowitz Bio + Health and an unnamed US-based life-sciences-focused investor, to further develop its AI platform for small-molecule drug discovery and expand its pipeline.

8/21/2023

A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $200M

Main topic: Genesis Therapeutics' $200 million Series B funding round for its AI-powered drug discovery platform in the biotech sector. Key points: 1. Genesis Therapeutics closed a $200 million Series B funding round, led by Andreessen Horowitz Bio + Health and an unnamed U.S.-based life-sciences-focused investor. 2. New investors in the round included Fidelity Management & Research Co., BlackRock, and Nvidia’s venture arm NVentures. 3. Genesis Therapeutics plans to use the funding to evolve into a clinical stage company, invest in its AI platform, and expand its discovery pipeline.

8/25/2023

Startups that are Ramp-ing up, and startups that are full of sh**

Main Topic: Recap of the week's startup and tech news Key Points: 1. Nvidia's impressive earnings report and growth 2. Ramp raises $300 million, despite a down-round, and reaches a valuation of $5.8 billion 3. Lex, an AI-powered writing tool, raises $2.75 million in seed funding.

8/30/2023

Generative AI startup AI21 Labs lands $155M at a $1.4B valuation

AI21 Labs, a text-generating AI startup, has raised $155 million in a Series C funding round, bringing its total raised to $283 million and valuing the company at $1.4 billion, with plans to expand its workforce and accelerate its R&D efforts.

9/12/2023

Druid Raises $30M to Expand Conversational AI for Customer Support with ChatGPT Integration

European AI startup Druid has raised $30 million in a Series B funding round to support its U.S. growth, which currently accounts for the majority of its revenue, as it expands its conversational business applications powered by generative AI.

9/14/2023

Databricks Raises $500M at $43B Valuation, Eyes Potential Bellwether IPO

Artificial intelligence and analytics firm Databricks has raised over $500 million in a Series I funding round, including strategic investor Nvidia, as it prepares for an anticipated IPO and expands its partnership with Nvidia to focus on generative AI. The fundraising round values Databricks at $43 billion and positions it as the eighth-most valuable private company globally. The company is closely monitoring the IPO market but will not be quick to go public, waiting for the macro environment to stabilize.

Topics

Posted 9/15/2023, 5:42:09 PM

Databricks Leads AI Startup Funding with $500M Round, Nvidia Backs Multiple Companies

Databricks raises $500M Series I at $43B valuation, including investment from Nvidia
Generate Biomedicines raises $273M Series C for AI drug discovery platform
Lyten raises $200M Series B for advanced materials and lithium-sulfur batteries
EquipmentShare raises $150M extension to April round, now totaling $440M
Enfabrica raises $125M Series B led by Atreides for AI networking chips, with investment from Nvidia

crunchbase.com

Relevant topic timeline:

8/18/2023

The Week’s 10 Biggest Funding Rounds: Biotech Startup Abcuro Takes Top Spot

8/21/2023

Berlin-based Lykon raises further €2.5 million to help 1 million people lose weight sustainably

8/21/2023

A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $200M

8/21/2023

A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $200M

8/25/2023

Startups that are Ramp-ing up, and startups that are full of sh**

8/30/2023

Generative AI startup AI21 Labs lands $155M at a $1.4B valuation

9/12/2023

Druid Raises $30M to Expand Conversational AI for Customer Support with ChatGPT Integration

9/14/2023

Databricks Raises $500M at $43B Valuation, Eyes Potential Bellwether IPO